Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours

  • Technology appraisal guidance
  • TA86
  • Published: 
  • Last updated: 
Download guidance (PDF)

8 Related guidance

National Institute for Clinical Excellence (2003) Guidance on the use of imatinib for chronic myeloid leukaemia.NICE Technology Appraisal Guidance No. 70. London: National Institute for Clinical Excellence.